Analytical Data
-
Gene name
EED
- Application
-
Alternative Names
HEED; WAIT1; WD Protein Associating With Integrin Cytoplasmic Tails 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75530
-
Expression Region
Asp142~Arg441
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EED (Embryonic Ectoderm Development) is a critical component of the Polycomb Repressive Complex 2 (PRC2), which plays a significant role in epigenetic regulation and gene silencing during development. The study of EED recombinant proteins has gained traction due to their essential functions in maintaining stem cell pluripotency and regulating cell differentiation. Abnormal EED activity is implicated in various cancers, making it a target for therapeutic interventions. Researchers have focused on producing EED recombinant proteins to better understand its structure-function relationships and molecular interactions. Through techniques like recombinant DNA technology, scientists can generate these proteins in host systems, allowing for detailed biochemical characterization and investigation into their roles in chromatin modification. By studying EED and its associated pathways, researchers aim to uncover novel insight into developmental biology and potential strategies for combating diseases linked to epigenetic dysregulation. The overall goal is to leverage these findings to develop targeted therapies that could selectively modulate EED function and restore proper gene expression patterns in affected tissues.
